港股異動 | 雅生活服務逆勢漲逾4% 匯豐環球大幅調升公司股價至39.8港元
格隆匯1月8日丨雅生活服務(3319.HK)逆勢收漲4.33%,報30.15港元再創新高,暫成交1.5億港元,最新總市值402億港元。同行業中,永升生活服務漲3.3%、奧園健康漲超1%。匯豐環球研報指,重申對雅生活服務“買入”評級,目標價由之前的29.7港元大幅調升至39.8港元,為中資物業管理行業首選。集團2018年至2021年的盈利年均複合增長率預計達38%,且估值具吸引力,目前相當於今年市盈率20倍。該行相信集團可滿足於下次指數審核(2月21日)中納入恆生小型股指數的標準,並有潛在可能獲納入南向通交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.